News

Recordings from MRA's 2023 Patient Forum

16 March 2023 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA’s 2023 Patient Forum brought together melanoma patients, survivors, advocates, and their loved ones to provide lay-friendly, state-of-the-science education and promote collaboration.

Read More


Facing Mucosal Melanoma, this Patient Turned to a TIL Clinical Trial

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 27 February 2023 In Melanoma Stories

In July of 2018, after a string of false starts and dead ends, Chris White was finally diagnosed with mucosal melanoma, a rare subtype of melanoma that forms on ‘wet tissues’ in the body. Mucosal melanoma accounts for about 1% of all melanoma diagnosis and can affect the nasal cavity,...

Read More


Sun Safety for the Melanoma Community

21 February 2023 In Events, Prevention

During a panel conversation at MRA's 2022 Patient Forum, Tracy Callahan, a five-time survivor of melanoma, was joined by Drs. Susan Swetter, Maria Wei, and Rachel Vogel to discus how people affected by melanoma can keep themselves and their loved ones safe from new melanomas while living life to the fullest.

Read More


From COVID-19 to Melanoma? The Bright Future of mRNA Vaccines

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 10 February 2023 In Science

Vaccines play an important role in keeping us healthy by protecting us from getting sick or by reducing the severity or duration of an illness. In addition to these preventive vaccines, researchers are also working to develop vaccines that treat disease, including melanoma, known as therapeutic vaccines.

Read More


Leading the Charge: MRA 2022 Annual Report

1 February 2023 In Allies & Partnerships, Melanoma Stories, News, Policy, Prevention, Science, Treatment

Since our inception in 2007, the Melanoma Research Alliance (MRA) has been laser-focused on advancing cutting-edge research needed to achieve our mission. With our singular vision, MRA stands as the largest private nonprofit funder of melanoma research in the world.

Read More


Melanoma at 33: A Testament to the Importance of Early Detection

By Renee Orcione, MRA Development Associate | 23 January 2023 In Melanoma Stories

Before he landed his current office job in the energy sector, Matthew Ruiz worked outdoors for many years. He, along with many of his colleagues in the field, took very few precautions to protect themselves from harmful UV rays. As is the unfortunate reality for many people with a history of significant sun exposure, this lifestyle came full circle for Matthew in 2018 when he was diagnosed with melanoma.

Read More


Nearly 100,000 Americans Estimated to be Diagnosed with Melanoma in 2023

By Joan Levy, PhD - MRA Chief Science Officer | 19 January 2023 In News, Prevention, Science, Treatment

Each January, the American Cancer Society (ACS) releases updated estimates about trends in new cancer cases and deaths in its annual report, Cancer Facts and Figures. This report highlights the estimated incidence (number of new cases), prevalence (number of people alive today with a history of cancer), and survival statistics for cancer in the United States.

Read More


Registration Now Open: MRA's 2023 Patient Forum

19 January 2023 In Allies & Partnerships, Events, News, Prevention, Science, Treatment

Registration for MRA's Melanoma Exchange Patient Forum, held in-person in Washington DC and virtually on Wednesday, March 8, is now open. Register now to hear from leading experts in the melanoma field and have the opportunity to ask questions, discuss, and network with other people who are going through their own melanoma journey.

Read More


Pioneering New Treatment Strategies for Melanoma

11 January 2023

Over the last few decades, the melanoma research community has made tremendous progress detecting several genes that when altered cause melanoma, including those involved in melanoma’s growth and development. In addition, scientists have uncovered key enzymes that regulate the expression of critical tumor-associated genes — called epigenetic factors.

Read More


Ask the Experts: Melanoma Research Update

8 December 2022

From promising clinical trial results to new treatment approaches and an evolving standard of care, 2022 has proven to be an exciting year of advances in melanoma research. As MRA continues to look ahead, we also want to take a moment to reflect on these advances and what they mean for melanoma patients, families, and the community at large.

Read More


Login

×